Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina

Mechanisms of Ageing and Development

Volumn 122, Issue 16, 2001, Pages 2057-2062

  Amici, Serena ^a   Lanari, Alessia ^a   Romani, Rita ^a   Antognelli, Cinzia ^a   Gallai, Virgilio ^a   Parnetti, Lucilla ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Acetylcholinesterase; Acetylcholinesterase inhibitors; Alzheimer's disease; Butyrylcholinesterase; Donepezil; Rivastigmine

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; ISOENZYME; RIVASTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; TREATMENT OUTCOME;

ACETYLCHOLINESTERASE; AGED; ALZHEIMER DISEASE; BUTYRYLCHOLINESTERASE; CARBAMATES; CHOLINESTERASE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; PHENYLCARBAMATES; PIPERIDINES; PROTEIN ISOFORMS; TIME FACTORS;

EID: 0034810297     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(01)00314-1     Document Type: Conference Paper

References (16)

1. Clinical benefits of a new piperidine-class AChE inhibitor
2. A new rapid colorimetric determination of acetylcolinesterase activity
3. Brain selective inhibition of acetylcholinesterase: A novel approach to therapy for Alzheimer's disease
4. Butyrylcholinesterase in the life cycle of amyloid plaques
5. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme
6. Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica
7. Clinical pharmacology of rivastigmine: A new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease
8. A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme
9. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
10. Donepezil improves cognition and global function in Alzheimer disease: A 15-week, double-blind, placebo-controlled study
11. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: Final analysis of a US multicentre open-label study
12. Molecular isoforms distribution and glycosilation of acetylcolinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease
13. Disaggregation of Alzheimer β-amyloid site-directed mAb
14. Guidelines for the appropriate use of cholinesterase inhibitors in patients with Alzheimer's disease
15. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society
16. Rivastigmine. A review of its use in Alzheimer's disease